Analysis of nearly 15,000 Covid-19 patients treated with these drugs within 24 hours of diagnosis shows a significant increase in mortality.
t. JUSTIN SULLIVAN / AFP
This is not yet the signal for the complete cessation of the use of chloroquine or hydroxychloroquine (HCQ) against Covid-19, but it is becoming more and more like it. The study published on May 22 in the benchmark scientific journal The Lancet should call out to those who, like US President Donald Trump, still think that if it doesn’t do any good, in any case it can’t do any harm!
The authors, led by Professor Mandeep Mehra of Harvard, however, take care not to strike anyone in the summary of their study. Especially since many prospective randomized study protocols, therefore of superior quality to this observational study, are still in progress.
“We have been unable to confirm a benefit of hydroxychloroquine or chloroquine (…) on the prognosis of hospitalized Covid-19 patients», They write. “Each of these protocols, when used for the treatment of Covid-19, has been associated with decreased survival in hospital and
